JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,628 ARS | -2.23% |
|
+3.49% | +34.47% |
| 07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
722721a6dd7c989b2e28.s5BvlXebGbBjfUPTMzVbsRtt9blI7CGpNTLwM_XaLqE.18Q67Tuvc9lWPASVbGcMgHYcmsEf3BHZcwC6B6DvaM_C9x3UOP13iFsZLA~39b476d65d258a0b49682f84e241681b
